Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2009 Aug;11(8):683-91.
doi: 10.1016/j.jfms.2009.05.016. Epub 2009 Jun 18.

Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins

R D Marshall  1 , J S Rand, J M Morton
Affiliations
Clinical Trial

Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins

R D Marshall et al. J Feline Med Surg. 2009 Aug.

Abstract

Glycaemic control and remission probabilities were compared in 24 newly diagnosed diabetic cats treated twice daily with either glargine, protamine zinc (PZI) or lente insulin and fed a low carbohydrate diet. After day 17, the probability of remission was substantially higher for cats with lower mean 12h blood glucose concentrations on day 17, irrespective of insulin type. Glargine-treated cats had lower mean 12h blood glucose concentrations on day 17 than PZI- or lente-treated cats, and all eight glargine-treated cats achieved remission compared to three PZI- and two lente-treated cats. The probability of remission was greater for cats treated with glargine than cats treated with PZI or lente insulin. In newly diagnosed diabetic cats, twice daily treatment with glargine provides better glycaemic control and higher probability of remission compared to twice daily treatment with PZI or lente insulin. Good glycaemic control soon after diagnosis is associated with increased probability of remission and should be the goal of insulin therapy.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Cumulative proportion of cats going into remission by time after initiation of treatment in a controlled trial comparing glycaemic control and remission probabilities in 24 newly diagnosed diabetic cats treated with glargine (– –), PZI – –) or lente (– –) insulin.
See this image and copyright information in PMC

References

    1. Panciera D.L., Thomas C.B., Eicker S.W., Atkins C. Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980–1986), J Am Vet Med Assoc 197, 1990, 1504–1508. - PubMed
    1. Rand J.S., Bobbermein L.M., Hendrikz J.K. Over-representation of Burmese in cats with diabetes mellitus in Queensland, Austral Vet J 75, 1997, 402–405. - PubMed
    1. Baral R.M., Rand J.S., Catt M.J., Farrow H.A. Prevalence of feline diabetes mellitus in a feline private practice, J Vet Int Med 17, 2003, 433–434.
    1. Bennett N., Greco D.S., Peterson M.E., Kirk C., Mathes M., Fettman M.J. Comparison of a low carbohydrate–low fiber diet and a moderate carbohydrate–high fiber diet in the management of feline diabetes mellitus, J Feline Med Surg 8, 2006, 73–84. - PMC - PubMed
    1. Martin G., Rand J.S. Pharmacology of a 40IU/ml porcine lente insulin preparation in diabetic cats. Findings during the first week and after five or nine weeks of therapy, J Feline Med Surg 3, 2001, 23–30. - PMC - PubMed

Publication types

MeSH terms